Different trends in antibiotic resistance rates at a university teaching hospital

Clinical Microbiology and Infection

Volumn 9, Issue 5, 2003, Pages 388-396

  Sörberg, Mikael ^a   Farra, A ^a   Ransjo U ^a   Gardlund B ^a   Rylander, M ^a   Settergren, B ^a   Kalin, M ^a   Kronvall, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibiotic resistance; Ciprofloxacin; Co trimoxazole; Escherichia coli; Pseudomonas aeruginosa; Resistance surveillance

Indexed keywords

AMPICILLIN; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; FUSIDIC ACID; GENTAMICIN; IMIPENEM; METICILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; ESCHERICHIA COLI; INTENSIVE CARE UNIT; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SWEDEN; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0038546797     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00545.x     Document Type: Article

References (52)

1. Hart CA. Antibiotic resistance: an increasing problem? It always has been, but there are things we can do. BMJ 1998; 316: 1255-6.
2. Casadevall A. Crisis in infectious diseases: time for a new paradigm? Clin Infect Dis 1996; 23: 790-4.
3. Goldmann DA, Weinstein RA, Wenzel RP et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996; 275: 234-40.
4. Salyers AA, Amabile-Cuevas CF. Why are antibiotic resistance genes so resistant to elimination? Antimicrob Agents Chemother 1997; 41: 2321-5.
5. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N Engl J Med 1994; 330: 1247-51.
6. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-96.
7. Mirza SH, Beeching NJ, Hart CA. Multi-drug resistant typhoid: a global problem. J Med Microbiol 1996; 44: 317-19.
8. Archibald L, Phillips L, Monnet D, McGowan Jr JE, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-15.
9. Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA 1999; 281: 67-71.
10. Itokazu GS, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 1996; 23: 779-84.
11. Harbarth S, Pittet D. Multiresistance of gram-negative bacteria in intensive care units: bad news from without. Crit care Med 1999; 27: 1037-38.
12. Asensio A, Oliver A, Gonzalez-Diego P et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000; 30: 55-60.
13. Carmeli Y, Troillet N, Karchmer AW, Samore MH. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999; 159: 1127-32.
14. de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355: 973-8.
15. Dornbusch K, King A, Legakis N. Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European collaborative study. European Study Group on Antibiotic Resistance (ESGAR). Scand J Infect Dis 1998; 30: 281-8.
16. Dornbusch K. Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. European Study Group on Antibiotic Resistance. J Antimicrob Chemother 1990; 26: 269-78.
17. Hanberger H, Hoffmann M, Lindgren S, Nilsson LE. High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden. Scand J Infect Dis 1997; 29: 607-14.
18. Wise R, Hart T, Cars O et al. Antimicrobial resistance. Is a major threat to public health. BMJ 1998; 317: 609-10.
19. Bornet C, Davin-Regli A, Bosi C, Pages JM, Bollet C. Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability. J Clin Microbiol 2000; 38: 1048-52.
20. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462-74.
21. Murray RE., Bdron EJ., Pfdller MA. et al. Manual of clinical microbiology. Washington, DC: ASM Press, 1999.
22. Crichton PB. Enterobacteriaceae; Escherichia, Klebsiella, Proteus and other genera. In: Collee JG, Fraser AG, Marmion BP, Simmons A, eds. Mackie and McCartney, practical medical microbiology. New York: Churchill Livingstone, 1996: 369.
23. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
24. Olsson-Liljequist B, Larsson P, Walder M, Miörner H. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis Suppl 1997; 105: 13-23.
25. Ringertz S, Olsson-Liljequist B, Kahlmeter G, Kronvall G. Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance. Scand J Infect Dis Suppl 1997; 105: 8-12.
26. Barry AL, Thornsberry C, Jones RN, Fuchs PC, Gavan TL, Gerlach EH. Reassessment of the 'class' concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins. Am J Clin Pathol 1978; 70: 909-13.
27. Olsson-Liljequist B, Forsgren A. Antimicrobial susceptibility testing in Sweden. I. The work of the Swedish Reference Group for Antibiotics (SRGA and SRGA-M). Scand J Infect Dis Suppl 1997; 105: 5-7.
28. Kahlmeter G, Olsson-Liljequist B, Ringertz S. Antimicrobial susceptibility testing in Sweden. IV. Quality assurance. Scand J Infect Dis Suppl 1997; 105: 24-31.
29. Andrews J, Ashby J, Jevons G, Marshall T, Lines N, Wise R. A comparison of antimicrobial resistance rates in Gram-positive pathogens isolated in the UK from October 1996 to January 1997 and October 1997 to January 1998. J Antimicrob Chemother 2000; 45: 285-93.
30. Fridkin SK, Steward CD, Edwards JR et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29: 245-52.
31. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA. Clin Infect Dis 1999; 29: 259-63.
32. Burwen DR, Banerjee SN, Gaynes RP. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis 1994; 170: 1622-5.
33. Widmer AF. Infection control and prevention strategies in the ICU. Intensive Care Med 1994; 20(suppl 4): S7-11.
34. Trilla A. Epidemiology of nosocomial infections in adult intensive care units. Intensive Care Med 1994; 20(suppl 3): S1-4.
35. Erlandsson CM, Hanberger H, Eliasson I et al. Surveillance of antibiotic resistance in ICUs in southeastern Sweden. ICU Study Group of the South East of Sweden. Acta Anaesthesiol Scand 1999; 43: 815-20.
36. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-44.
37. Lucet JC, Decre D, Fichelle A et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis 1999; 29: 1411-18.
38. Monnet DL, Archibald LK, Phillips L, Tenover FC, McGowan JE Jr, Gaynes RP. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol 1998; 19: 388-94.
39. Frank UJD, Lupke T. Antimicrobial susceptibility among nosocomial pathogens isolated in intensive care units in Germany. Eur J Clin Microbiol Infect Dis 2000; 19: 888-91.
40. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee [published erratum appears in Infect Control Hosp Epidemiol 1996; April; 17(4): 214]. Infect Control Hosp Epidemiol 1996; 17: 53-80.
41. Hartstein AI, Denny MA, Morthland VH, LeMonte AM, Pfaller MA. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 1995; 16: 405-11.
42. Jernigan JA, Clemence MA, Stott GA et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995; 16: 686-96.
43. Chetchotisakd P, Phelps CL, Hartstein AI. Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units. Clin Infect Dis 1994; 18: 929-37.
44. Kibbler CC, Quick A, O'Neill AM. The effect of increased bed numbers on MRSA transmission in acute medical wards. J Hosp Infect 1998; 39: 213-19.
45. Sörensen TL, Frimodt-Möller N, Espersen F. Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995. Clin Microbiol Infect 1998; 4: 422-30.
46. Livermore DM, Threlfall EJ, Reacher MH et al. Are routine sensitivity test data suitable for the surveillance of resistance? Resistance rates amongst Escherichia coli from blood and CSF from 1991-1997, as assessed by routine and centralized testing. J Antimicrob Chemother 1991; 45: 205-11.
47. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999; 43: 1379-82.
48. Hanberger H, Nilsson LE, Claesson B et al. New species-related MIC breakpoints for early detection of development of resistance among Gram-negative bacteria in Swedish intensive care units. J Antimicrob Chemother 1999; 44: 611-19.
49. Tsakris A, Pournaras S, Woodford N et al. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol 2000; 38: 1290-2.
50. Reacher MH, Shah A, Livermore DM et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000; 320: 213-16.
51. Cockerill FR 3rd, Hughes JG, Vetter EA et al. Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clin Infect Dis 1997; 24: 403-18.
52. Johnson AP. Antibiotic resistance among clinically important gram-positive bacteria in the UK. J Hosp Infect 1998; 40: 17-26.